This trial is studying proton beam radiation therapy and intensity-modulated radiation therapy to see how well they work in preserving brain function in patients with IDH mutant grade II or III glioma.
1 Primary · 9 Secondary · Reporting Duration: Up to 10 years
120 Total Participants · 2 Treatment Groups
Primary Treatment: Proton Beam Radiation Therapy · No Placebo Group · Phase 2
Age 18+ · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: